The Endocrine Society's 2023 clinical practice guideline on pharmacologic management of obesity notes that GLP-1 receptor agonists may affect oral drug absorption but emphasizes that "clinically significant reductions in efficacy have not been demonstrated for most co-administered medications" [7]
Weissman JR, Kelley RI, Bauman ML, Cohen BH, Murray KF, et al
Yes, Noveltreat can be used alongside other antidiabetic medications, but only under medical supervision
It boosts the body's metabolism
federal law because it is an investigational drug, not eligible under sections 503A or 503B
If you see a little blood, dont worry this is common